Condition
Baseline
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 1 (1)
Trial Status
Completed2
Unknown1
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT04878965Not ApplicableCompletedPrimary
Smartwatches to Manage Stress and Anxiety in Residential Settings
NCT02179827WithdrawnPrimary
Performance of Non-Invasive Monitors During ANH
NCT04317157Not ApplicableUnknown
Placebo Effects Investigated by Different Experimental Designs
NCT02181582Phase 1CompletedPrimary
Specific PET Radioligand Binding to Translocator Protein
Showing all 4 trials